CNC
Centene Corp
NYSE: CNC · HEALTHCARE · HEALTHCARE PLANS
$56.36
-0.59% today
Updated 2026-06-05
Market cap
$32.19B
P/E ratio
—
P/S ratio
0.18x
EPS (TTM)
$-13.05
Dividend yield
—
52W range
$25 – $67
Volume
5.9M
WallStSmart proprietary scores
57
out of 100
Grade: C+
Hold
Investment rating
7.3
Growth
B+6.5
Quality
B3.5
Profitability
D7.0
Valuation
B+6/9
Piotroski F-Score
Moderate
2.8
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$61.35
+8.85%
12-Month target
—
—
Intrinsic (DCF)
$269.76
Margin of safety
+85.01%
1 Strong Buy6 Buy12 Hold1 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Free cash flow $3.40B — positive
+ 85.01% below intrinsic value
Risks
- Thin margins at -3.61%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $144.55B | $154.00B | $163.07B | $194.78B | $178.33B |
| Net income | $1.20B | $2.70B | $3.31B | $-6.67B | $1.54B |
| EPS | — | — | — | — | $-13.05 |
| Free cash flow | $5.26B | $7.25B | $-490.00M | $4.32B | $3.40B |
| Profit margin | 0.83% | 1.75% | 2.03% | -3.43% | -3.61% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-05-29 | CARSON, MICHAEL A | Sale | 604 | $59.60 |
| 2026-05-22 | CARSON, MICHAEL A | Buy | 48 | $57.77 |
| 2026-05-12 | TANJI, KENNETH | Buy | 3,992 | — |
Peer comparison
Smart narrative
Centene Corp trades at $56.36. Our Smart Value Score of 57/100 indicates the stock is fair. The company scores 6/9 on the Piotroski F-Score. With an Altman Z-Score of 2.83, it sits in the grey zone. TTM revenue stands at $178.33B. with profit margins at -3.61%. Our DCF model estimates intrinsic value at $269.76.
Frequently asked questions
What is Centene Corp's stock price?
Centene Corp (CNC) trades at $56.36, on a P/S of 0.2x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Centene Corp overvalued?
Centene Corp carries a Smart Value Score of 57/100 (Grade C+), which we rate Hold. That score blends growth, quality, and valuation into one read. Our DCF puts intrinsic value at $269.76 versus the $56.36 price, a 85.0% margin of safety on a cash flow basis.
What is the price target of Centene Corp (CNC)?
The 12-month analyst consensus target is $61.35, about 8.9% above the current $56.36. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the intrinsic value of Centene Corp (CNC)?
Our DCF model estimates intrinsic value at $269.76, a +85.0% margin of safety versus today's $56.36. Intrinsic value is what the projected cash flows are worth today. A positive reading means the price sits below that estimate, leaving a cushion if growth holds.
What is Centene Corp's revenue?
Centene Corp's trailing twelve-month revenue is $178.33B. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Centene Corp's Altman Z-Score is 2.83, which places it in the grey zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryHEALTHCARE PLANS
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio0.18x
ROE-30.07%
Beta1.09
50D MA$51.70
200D MA$41.39
Shares out0.49B
Float0.46B
Short ratio—
Avg volume5.9M
Performance
1 week+0.00%
1 month+6.97%
3 months+80.93%
YTD+51.47%
1 year—
3 years—
5 years—